 with any level of heart failure. In addition to improving blood ï¬‚ow to the limb, there is evidence
that cilostazol and pentoxifylline prevent lipid accumulation,
oxidation, and coagulation (ie, preventing further progression of atherosclerosis). However, epidemiologic evidence
suggests that many patients do not receive meaningful symptom relief with medical therapy alone. This is likely a result of
the limited ability of drugs to enhance muscle function or
limb blood